title: Minimum effective dose and duration to reverse neutropenia in non-cancer patients with advanced HIV disease.
authors.forename: P
authors.initials: P
authors.lastname: Hermans
authors.forename: P
authors.initials: P
authors.lastname: Franchioly
authors.forename: C
authors.initials: C
authors.lastname: Thioux
authors.forename: S J
authors.initials: SJ
authors.lastname: Gray
authors.forename: H
authors.initials: H
authors.lastname: Vannerom
authors.forename: N
authors.initials: N
authors.lastname: Clumeck
mesh_terms: D000328:Adult; D002648:Child; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology
chemical_list: D016179:Granulocyte Colony-Stimulating Factor